ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tomasz Beer, MD
Oregon Health and Science University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Vancouver Cancer Center
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- London Regional Cancer Centre
London, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Princess Margaret Hospital, University Health Network
Toronto, Ontario, Canada
- Toronto-Sunnybrook Regional Cancer Center
Toronto, Ontario, Canada
- Chum / Notre-Dame Hospital
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec, Hotel-Dieu de Quebec
Québec, Quebec, Canada
- Montgomery Cancer Center
Montgomery, Alabama, United States
- Arizona Cancer Center- Scottsdale
Scottsdale, Arizona, United States
- Arizona Cancer Center- Tucson
Tucson, Arizona, United States
- Arizona Cancer Center/southern Arizona Va Hcs
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences / Central Ar Va
Little Rock, Arkansas, United States
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- California Cancer Care
Greenbrae, California, United States
- Tower Hematology Oncology Medical Group
Los Angeles, California, United States
- Prostate Oncology Specialist/pacific Clinical Research
Marina del Rey, California, United States
- Uc Davis Comprehensive Cancer Center
Sacramento, California, United States
- Sharp Healthcare
San Diego, California, United States
- Southern California Permanente Medical Group
San Diego, California, United States
- Pacific Hematology Oncology Associates
San Francisco, California, United States
- Kaiser- Northern California
Vallejo, California, United States
- San Diego Cancer Center
Vista, California, United States
- Oncology Hematology Associates, Paudre Calley Cancer Ctr.
Fort Collins, Colorado, United States
- University of Miami-Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Oncology Hematology Consultants
Sarasota, Florida, United States
- Georgia Urology, P.A.
Atlanta, Georgia, United States
- Georgia Cancer Specialists
Tucker, Georgia, United States
- Loyola University Medical
Maywood, Illinois, United States
- Midwest Cancer Research Group
Skokie, Illinois, United States
- Urologic Associates- P.C.
Davenport, Iowa, United States
- Oncology Hematology Care
Crestview Hills, Kentucky, United States
- Tulane University Hospital and Clinic
New Orleans, Louisiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Associates in Oncology Hematology P.C.
Rockville, Maryland, United States
- Metro Minnesota Ccop
Saint Louis Park, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- Univ. of Nebraska Medical Center/va Hospital
Omaha, Nebraska, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2002
- Primary completion
- —
- Completion
- 31 Dec 2005
- Last update posted
- 12 Mar 2009
- Registered enrollment
- 250
- Registry id
- NCT00043576
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.